Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation
Related Experiment Video
Updated: Mar 18, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1Department of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education.
Abstract:
The homologous proteins MDM2 and MDMX negatively regulate the tumor suppressor protein p53 by antagonizing p53 transactivation activity and targeting p53 for degradation. MDM2 and MDMX bind to p53 via N-terminal p53-binding domains to control the level of p53. The N-terminal regions of MDM2 and MDMX are modified in vivo under stressed conditions, suggesting that modifications to MDM2/MDMX also may affect the p53-MDM2/MDMX interaction. Ample evidence suggests that the MDM2 lid (residues 1-24) is partially structured and significantly reduces its binding affinity with p53 several fold. Since MDM2 and MDMX possess very similar p53-binding domains but different lids, however, the function of the N-terminal lid of MDMX still remains poorly understood. Using a native chemical ligation technique, the p53-binding domain of MDMX, (1-108)MDMX, and its N-terminal lid (residues 1-23) truncated analogue (24-108)MDMX were chemically synthesized. We comparatively characterized their structures by circular dichroism (CD) spectra, and measured their binding affinities with a panel of p53-derived peptide ligands by fluorescence polarization and surface plasmon resonance assays. Our results indicate that, as opposed to the lid of MDM2, the lid of MDMX has little effect on p53-binding, adopts no structural conformation, and has rare auto-inhibitory function. Different lid modifications of MDM2 and MDMX are functionally different with respect to p53 binding, which should be considered when designing dual specific inhibitors of MDM2 and MDMX.
Insights
The MDM2 and MDMX proteins regulate tumor suppressor p53. Unlike MDM2, the MDMX protein
Area of Science:
- Oncology
- Molecular Biology
- Protein Interactions
Background:
- MDM2 and MDMX are homologous proteins that negatively regulate the tumor suppressor p53.
- They bind to p53 via N-terminal domains, controlling p53 levels.
- N-terminal modifications of MDM2/MDMX under stress may impact p53 interactions.
Purpose of the Study:
- To investigate the function of the N-terminal lid of MDMX in p53 binding.
- To compare the structural and binding characteristics of MDMX with and without its lid.
- To understand the differential roles of MDM2 and MDMX lids in p53 regulation.
Main Methods:
- Chemical synthesis of MDMX variants ((1-108)MDMX and (24-108)MDMX) using native chemical ligation.
- Structural characterization using circular dichroism (CD) spectra.
- Binding affinity measurements with p53 peptides using fluorescence polarization and surface plasmon resonance (SPR).
Main Results:
- The lid of MDMX (residues 1-23) has minimal impact on p53 binding affinity.
- The MDMX lid does not adopt a defined structural conformation and exhibits limited auto-inhibitory function.
- In contrast, the MDM2 lid significantly reduces p53 binding affinity.
Conclusions:
- The N-terminal lids of MDM2 and MDMX play functionally distinct roles in p53 binding.
- These differences should be considered when developing dual inhibitors targeting both MDM2 and MDMX.
- Understanding these lid-specific functions is crucial for cancer therapy development.
More Related Videos
08:38Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells
Published on: March 3, 2015
06:38High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019